← Back to Search

Dairy Product

A2 vs Regular Milk for Lactose Intolerance

N/A
Recruiting
Led By Dennis Savaiano, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Agrees to refrain from all other treatments and products used for dairy intolerance (e.g., Lactaid® Dietary Supplements) during study involvement
Aged 18 to 65 years of age inclusive at screening
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from day 1 to day 14 after 500 ml milk consumption and within the 6 hours following milk dose on day 15
Awards & highlights

Study Summary

This trial shows that milk with A1 protein leads to more symptoms of lactose intolerance & inflammation than milk with A2.

Who is the study for?
Adults aged 18-65 with a history of lactose intolerance who have avoided dairy for at least a month can join. They must be willing to attend all study visits, avoid other dairy intolerance treatments during the trial, and not have conditions like severe ulcers, diabetes, milk allergies, heart failure or recent drug/alcohol abuse.Check my eligibility
What is being tested?
This study is testing how two types of milk affect people with lactose intolerance. One has only A2 beta-casein; the other has both A1 and A2. It's double-blinded (neither researchers nor participants know who gets which milk) and randomized to see if there are differences in inflammation after two weeks.See study design
What are the potential side effects?
Potential side effects may include typical symptoms of lactose intolerance such as gas, bloating, diarrhea, cramps or stomach pain due to consumption of milk containing A1 beta-casein.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I agree not to use any products for dairy intolerance during the study.
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from day 1 to day 14 after 500 ml milk consumption and within the 6 hours following milk dose on day 15
This trial's timeline: 3 weeks for screening, Varies for treatment, and from day 1 to day 14 after 500 ml milk consumption and within the 6 hours following milk dose on day 15 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Difference in hydrogen between commercial and A2 milk
Difference in inflammation between commercial and A2 milk
Difference in symptoms between commercial and A2 milk

Trial Design

2Treatment groups
Experimental Treatment
Group I: Old World milkExperimental Treatment1 Intervention
Old World milk containing only a2 beta-casein vs. New World milk that includes both a1 and a2 beta-casein
Group II: New World milkExperimental Treatment1 Intervention
Old World milk containing only a2 beta-casein vs. New World milk that includes both a1 and a2 beta-casein

Find a Location

Who is running the clinical trial?

Purdue UniversityLead Sponsor
224 Previous Clinical Trials
72,729 Total Patients Enrolled
3 Trials studying Lactose Intolerance
80 Patients Enrolled for Lactose Intolerance
Dennis Savaiano, PhDPrincipal InvestigatorPurdue University
4 Previous Clinical Trials
928 Total Patients Enrolled
3 Trials studying Lactose Intolerance
80 Patients Enrolled for Lactose Intolerance

Media Library

Milk containing A1 and A2 beta-casein (Dairy Product) Clinical Trial Eligibility Overview. Trial Name: NCT05669274 — N/A
Lactose Intolerance Research Study Groups: Old World milk, New World milk
Lactose Intolerance Clinical Trial 2023: Milk containing A1 and A2 beta-casein Highlights & Side Effects. Trial Name: NCT05669274 — N/A
Milk containing A1 and A2 beta-casein (Dairy Product) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05669274 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age cap for this research extend beyond 25 years of age?

"As outlined in the eligibility requirements, the minimum age to partcipate is 18 and no older than 65."

Answered by AI

What qualifications are necessary to be an eligible participant in this research?

"This trial is seeking 35 individuals aged 18-65 with lactose intolerance. To qualify, candidates must present a current or recent aversion to dairy products that has lasted for at least one month as evidenced by self-reported symptoms and experiences."

Answered by AI

How many participants are involved in this trial?

"Indeed, the research being conducted is actively looking for participants. The trial that was initially posted on December 2nd 2021 has seen its most recent update happen as recently as March 27th 2023. 35 individuals from a single site are needed to join this experiment."

Answered by AI

Are there any vacancies for participants in this medical trial?

"Clinicaltrials.gov reveals that this trial is still open for recruitment, with the first advertisement posted on December 2nd 2021 and the most recent edit made March 27th 2023."

Answered by AI
~7 spots leftby Dec 2024